COVID-19 pneumonia can cause irreversible lung damage in dermatomyositis with pre-existing interstitial lung disease

Int J Rheum Dis. 2021 Sep;24(9):1221-1223. doi: 10.1111/1756-185X.14204. Epub 2021 Aug 9.

Authors

Satoshi Hama¹, Mitsuhiro Akiyama^{1

2}, Tatsuya Shimada^{1

2}, Misako Higashida-Konishi¹, Hiroshi Takei^{1

2}, Keisuke Izumi^{1

2}, Hisaji Oshima¹, Yutaka Okano¹

Affiliations

¹ Department of Connective Tissue Diseases, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
² Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.

No abstract available

Keywords: COVID-19; SARS-CoV-2; dermatomyositis; interstitial lung disease.

Publication types

Case Reports
Letter

MeSH terms

Aged
COVID-19 / diagnosis
COVID-19 / epidemiology*
Comorbidity
Dermatomyositis / epidemiology*
Humans
Lung / diagnostic imaging*
Lung Diseases, Interstitial / diagnosis
Lung Diseases, Interstitial / epidemiology*
Male
SARS-CoV-2*
Tomography, X-Ray Computed